168 filings
Page 3 of 9
8-K
uduxc9
6 May 20
Ironwood Pharmaceuticals Reports First Quarter 2020 Results and Provides Update on Impact of COVID-19 Pandemic
4:08pm
8-K
9lerqxol7y 5p24t
21 Apr 20
Departure of Directors or Certain Officers
4:07pm
8-K
yt6alq0m2sc
16 Mar 20
Regulation FD Disclosure
6:16am
8-K
g35azmdlz2bhj
13 Feb 20
Results of Operations and Financial Condition
7:05am
8-K
cu9y6ml7
13 Jan 20
1 J.P. Morgan 38 th Annual Healthcare Conference Ironwood Pharmaceuticals January 2020
8:31am
8-K
q6xus udto
31 Oct 19
Results of Operations and Financial Condition
7:06am
8-K
3wqs zsrfzscweb6zg
18 Sep 19
Entry into a Material Definitive Agreement
8:00am
8-K
su22chi owzzs5
16 Sep 19
Termination of a Material Definitive Agreement
5:12pm
8-K
p2qbk
14 Aug 19
Entry into a Material Definitive Agreement
12:00am
8-K
ts17 fptd0wrk2nvo
13 Aug 19
Entry into a Material Definitive Agreement
5:20pm
8-K
mweglp96 x8k1vk2ug5i
1 Aug 19
Entry into a Material Definitive Agreement
4:22pm
8-K
20ijvnz1ctz 8xar
30 Jul 19
Ironwood Pharmaceuticals Reports Second Quarter 2019 Results
4:05pm
8-K
3ltctg
22 Jul 19
Other Events
4:04pm
8-K
jqpbrx0hc584uhy7a
10 Jul 19
Departure of Directors or Certain Officers
4:00pm
8-K
nzictn rjeubq6h
13 Jun 19
Ironwood Pharmaceuticals to Establish New Headquarters in Downtown Boston
4:37pm
8-K
mctu14jccn5vouinr
31 May 19
Material Modifications to Rights of Security Holders
4:05pm
8-K
xkjwqsrqzfp7rdg
14 May 19
Results of Operations and Financial Condition
8:00am
8-K/A
jtdzehtg
3 May 19
Departure of Directors or Certain Officers
4:06pm
8-K
pd0c7ludz9km
2 May 19
Ironwood Pharmaceuticals Reports First Quarter 2019 Results; Announces Positive 2019 Adjusted EBITDA from Continuing Operations Guidance
7:45am
8-K
o3ot lcsan7hc
8 Apr 19
Entry into a Material Definitive Agreement
4:45pm